We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 18

FDA shuts down fish processing plant because of unsanitary conditions
  • Norton Rose Fulbright
  • USA
  • December 22 2014

The Food and Drug Administration ("FDA") has shut down the Los Angeles based Neptune Manufacturing Inc. ("Neptune") because of longstanding


FDA announces that BPA in food is safe; concern over the additive remains
  • Norton Rose Fulbright
  • USA
  • December 22 2014

Last week the Food and Drug Administration ("FDA") announced the conclusions of its four-year review of the safety of the synthetic compound


FSMA update: revised proposed rules receive mixed reviews as comment period closes
  • Norton Rose Fulbright
  • USA
  • December 22 2014

The Food Safety Modernization Act ("FSMA") grants the FDA broad powers to make and enforce regulations aimed at preventing microbial contamination of


FDA issues new menu labeling rules
  • Norton Rose Fulbright
  • USA
  • December 22 2014

Last month, the Food and Drug Administration ("FDA") issued final rules that require restaurants, grocery stores, and other types of food businesses


FDA Warning Letter update
  • Norton Rose Fulbright
  • USA
  • December 22 2014

It is FDA's practice to issue Warning Letters in order to provide individuals and companies an opportunity to take voluntary and prompt corrective


Taiwanese gutter oil scandal highlights food safety
  • Norton Rose Fulbright
  • USA, Taiwan
  • September 23 2014

A scandal involving the production of food using oil recycled from restaurant waste and slaughterhouse byproducts is currently unfolding in Taiwan


FDA Warning Letter update - July 2014
  • Norton Rose Fulbright
  • USA
  • July 18 2014

It is FDA's practice to issue Warning Letters in order to provide individuals and companies an opportunity to take voluntary and prompt corrective action before it initiates an enforcement action.


FDA releases first biannual progress report on its strategy to promote judicious antimicrobials in food-producing animals
  • Norton Rose Fulbright
  • USA
  • July 18 2014

On June 30, 2014, the Food and Drug Administration ("FDA") released its first biannual progress report on its strategy to reduce antimicrobial


Pharmaceutical industry scores major victory as class action is dismissed
  • Norton Rose Fulbright
  • Canada
  • May 31 2012

The Quebec Court of Appeal has sided with respondents Wyeth Consumer Healthcare Inc and Johnson & Johnson Inc in dismissing an appellant's motion for a class action.


The pharmaceutical industry scores a major victory: Court of Appeal refuses to authorize a class action
  • Norton Rose Fulbright
  • Canada
  • May 11 2012

In a judgment rendered on April 19, 2012,1 the Quebec Court of Appeal sided with the respondents Wyeth Consumer Healthcare Inc. and Johnson & Johnson Inc. and confirmed the dismissal of the appellant’s motion for authorization to institute a class action.